Prime Minister Narendra Modi on Friday chaired a high-level meeting on the Covid situation and vaccination as the government noted high caseloads in states like Kerala and Maharashtra to say that there can be no room for complacency.
Modi reviewed the status of augmentation of bed capacity for pediatric care and of facilities supported under "COVID Emergency Response Package II", and it was noted that states have been advised to redesign and orient primary care and block level health infrastructure in these areas to manage the situation in rural areas, a statement said.
States are being asked to maintain a buffer stock for drugs used in management of COVID-19, mucormycosis, MIS-C at the district level, it added.
"It was discussed that across the world, there are countries where the number of active Covid cases continues to remain high. In India too, the figures from states like Maharashtra and Kerala indicate that there can be no room for complacency," the statement said.
However, the weekly positivity was at less than three per cent for the 10th consecutive week, it added.
Modi underscored the need to rapidly augment the entire ecosystem to ensure increased oxygen availability, including oxygen concentrators, cylinders and PSA plants.
Efforts are also on to install 961 Liquid Medical Oxygen storage tanks and 1,450 medical gas pipeline systems with an aim to support at least one such unit per district, the government said.
The ambulance network is also being augmented to ensure at least one ambulance per block.
Modi also reviewed the status of PSA oxygen plants coming up across the country and told that around one lakh oxygen concentrators and three lakh oxygen cylinders have been distributed to states.
He was also briefed about the concentration of cases in a few geographies, districts with high test positivity as well as the week on week test positivity rate in the country.
On vaccines, the statement noted that around 58 per cent of India's adult population has received the first dose and nearly 18 per cent both doses.
Modi was also updated about the vaccine pipeline and increased supply of vaccines.
He spoke about the need for constant genome sequencing to monitor emergence of mutants.
He was informed that INSACOG (SARS-CoV-2 Genomic Consortium) now consists of 28 labs distributed across the country.
The lab network is also linked with a hospital network for clinical correlation. Sewage sampling is also being done for genomic surveillance. States have been requested to share SARS COV2 positive samples with INSACOG regularly.
Modi highlighted the need to ensure adequate testing across the country and was told about the support being given to 433 districts to establish RT-PCR lab facility in public health facilities.
The principal secretary to the prime minister, cabinet secretary, principal scientific advisor, health secretary, member (health) NITI Aayog and other important officials were present in the meeting.
The meeting came a day after Union Health Secretary Rajesh Bhushan said India is still going through the second wave of COVID-19 and it is not over yet.
He had said 35 districts are still reporting a weekly Covid positivity rate of over 10 per cent while it is between five and 10 per cent in 30 districts.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)